EosGene Therapeutics is pioneering the next generation of gene therapy with NanoSyringe, a light-activated delivery platform designed for precise, scalable, and cost-effective genetic medicine. The therapy will remove the need for painful eye injections in those suffering from diabetic retinopathy and age-related macular degeneration.
We recently launched a special podcast series dedicated to the Australian Clinical Entrepreneur Program (AUSCEP) where we introduce you to some of the passionate health professionals who took part in our 2024-25 program to develop their innovative ideas into products and enterprises.
Tune in to find out how the program has made an impact in these four new episodes – and get inspired!
